These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 16766648)

  • 1. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of angiotensin peptides in the urine of hypertensive animals.
    Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM
    Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
    Trask AJ; Averill DB; Ganten D; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3019-24. PubMed ID: 17308000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
    Varagic J; Ahmad S; VonCannon JL; Moniwa N; Brosnihan KB; Wysocki J; Batlle D; Ferrario CM
    Am J Hypertens; 2013 May; 26(5):583-90. PubMed ID: 23459599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
    Jessup JA; Westwood BM; Chappell MC; Groban L
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):245-57. PubMed ID: 19531557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat.
    Pendergrass KD; Averill DB; Ferrario CM; Diz DI; Chappell MC
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1497-506. PubMed ID: 16403834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
    Hamming I; van Goor H; Turner AJ; Rushworth CA; Michaud AA; Corvol P; Navis G
    Exp Physiol; 2008 May; 93(5):631-8. PubMed ID: 18192334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converting enzyme determines plasma clearance of angiotensin-(1-7).
    Yamada K; Iyer SN; Chappell MC; Ganten D; Ferrario CM
    Hypertension; 1998 Sep; 32(3):496-502. PubMed ID: 9740616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pouch tissue and angiotensin peptide generation.
    Katwa LC; Sun Y; Campbell SE; Tyagi SC; Dhalla AK; Kandala JC; Weber KT
    J Mol Cell Cardiol; 1998 Jul; 30(7):1401-13. PubMed ID: 9710808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney.
    Westwood BM; Chappell MC
    Peptides; 2012 Jun; 35(2):190-5. PubMed ID: 22490446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
    Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.
    Pendergrass KD; Pirro NT; Westwood BM; Ferrario CM; Brosnihan KB; Chappell MC
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H10-20. PubMed ID: 18456730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.
    Yamaleyeva LM; Gilliam-Davis S; Almeida I; Brosnihan KB; Lindsey SH; Chappell MC
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1374-84. PubMed ID: 22378820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
    Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.